Abbott Laboratories is adding HPV screening to its "Alinity m" family of diagnostic assays following U.S. Food & Drug Administration approval. Abbott said in a press release that the FDA approved its ...
Abbott’s Alinity m Resp-4-Plex molecular assay, which was designed to test for four viruses in one test, has been authorized for emergency use by the US Food and Drug Administration (FDA). Shares of ...
Abbott Laboratories, Inc. ABT recently announced the receipt of the FDA approval for the Alinity i laboratory traumatic brain injury (TBI) blood test. This will be the first commercially available TBI ...
-- Abbott's Alinity™ m Resp-4-Plex assay will allow healthcare workers to test for four viruses in one test, a critically important tool as flu presents with similar symptoms -- The test helps save on ...
According to the U.S. Centers for Disease Control (CDC), most sexually active adults will experience HPV infections; new test detects those HPV genotypes that could lead to cancer Abbott (ABT)'s new ...
The newly approved Alinity m high risk human papillomavirus (HPV) assay is indicated to detect HPV and for use in routine cervical cancer screening per professional medical guidelines. The FDA has ...
How important are diagnostic tests in clinical decision making? Diagnostic tests are critical as up to 60 to 70% of critical clinical decisions are influenced by diagnostic test results. It's of huge ...
The FDA urged clinical laboratories and healthcare providers to retest any patients who have recently received a positive result from two of Abbott’s PCR COVID-19 assays after identifying a heightened ...
ABBOTT PARK, Ill., Nov. 2, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) has received U.S. Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback